| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.9M | -51.3% |
| R&D Expense | $46.4M | -6.1% |
| SG&A Expense | $14.6M | +15.8% |
| Operating Income | -$56.2M | -8.0% |
| Interest Expense | $307K | -36.4% |
| Income Tax | $0 | — |
| Net Income | -$53.0M | -10.7% |
| EPS (Basic) | -$1.29 | -4.0% |
| EPS (Diluted) | -$1.29 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.8M | -59.8% |
| Current Assets | $44.2M | -56.7% |
| Total Assets | $45.2M | -56.5% |
| Current Liabilities | $15.2M | -37.7% |
| Long-term Debt | $1.8M | -50.4% |
| Total Liabilities | $16.4M | -40.3% |
| Stockholders' Equity | $28.8M | -62.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.0M | -68.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | -$1.6M | -103.3% |
| Free Cash Flow | -$56.0M | -68.2% |
| -4.0% |